Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $10.41 million. The enterprise value is -$2.87 million.

Market Cap	10.41M
Enterprise Value	-2.87M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PHIO has 4.80 million shares outstanding. The number of shares has decreased by -46.52% in one year.

Current Share Class	4.80M
Shares Outstanding	4.80M
Shares Change (YoY)	-46.52%
Shares Change (QoQ)	+278.75%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	19.29%
Float	4.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.85
P/TBV Ratio	0.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.58

Current Ratio	10.58
Quick Ratio	10.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -76.12% and return on invested capital (ROIC) is -49.58%.

Return on Equity (ROE)	-76.12%
Return on Assets (ROA)	-43.43%
Return on Invested Capital (ROIC)	-49.58%
Return on Capital Employed (ROCE)	-57.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.57% in the last 52 weeks. The beta is 0.85, so PHIO's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-65.57%
50-Day Moving Average	2.14
200-Day Moving Average	2.29
Relative Strength Index (RSI)	48.50
Average Volume (20 Days)	704,461

Short Selling Information

The latest short interest is 240,898, so 5.02% of the outstanding shares have been sold short.

Short Interest	240,898
Short Previous Month	226,845
Short % of Shares Out	5.02%
Short % of Float	5.04%
Short Ratio (days to cover)	0.35

Income Statement

Revenue	n/a
Gross Profit	-3.67M
Operating Income	-7.05M
Pretax Income	-9.38M
Net Income	-6.77M
EBITDA	-7.05M
EBIT	-7.05M
Earnings Per Share (EPS)	-$9.41

Full Income Statement

Balance Sheet

The company has $13.28 million in cash and n/a in debt, giving a net cash position of $13.28 million or $2.77 per share.

Cash & Cash Equivalents	13.28M
Total Debt	n/a
Net Cash	13.28M
Net Cash Per Share	$2.77
Equity (Book Value)	12.17M
Book Value Per Share	2.55
Working Capital	12.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.38 million and capital expenditures -$3,000, giving a free cash flow of -$6.38 million.

Operating Cash Flow	-6.38M
Capital Expenditures	-3,000
Free Cash Flow	-6.38M
FCF Per Share	-$1.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	46.52%
Shareholder Yield	46.52%
Earnings Yield	-64.97%
FCF Yield	-61.27%

Analyst Forecast

The average price target for PHIO is $9.00, which is 314.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	314.75%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2